Free Sale Certificate (FSC) for Pharma Exports: What It Is and When You Need It

If you are registering or importing pharmaceutical products from India in a new market, there is a good chance your country's regulatory authority will ask for a Free Sale Certificate (FSC). It is one of the most commonly required import documentation elements — and one that requires lead time to obtain. Understanding it upfront avoids delays in your shipment or registration process.

---

What Is a Free Sale Certificate?

A Free Sale Certificate (also called a Certificate of Free Sale, or when formatted to WHO specifications, a Certificate of Pharmaceutical Product / CPP) is an official document issued by a competent authority in the exporting country attesting that:

1. The product is freely marketed and sold in the country of origin (India) 2. The manufacturer holds a valid manufacturing licence issued by the competent authority 3. The product conforms to applicable standards

It essentially tells the importing country's regulatory authority: "This product is legal, licensed, and commercially available in India — it is not a prohibited or experimental product."

The FSC does not attest to clinical efficacy or safety — it is a trade and regulatory legitimacy document, not a clinical endorsement.

---

Who Issues FSCs in India?

FSCs for pharmaceutical products can be issued by:

- CDSCO (Central Drugs Standard Control Organisation): Issues the WHO-format Certificate of Pharmaceutical Product (CPP) for products manufactured under a Central Licence (e.g., certain biologics, large-volume parenterals, vaccines) - State Drug Controllers / State FDAs: Issue FSCs for products manufactured under State licences — which covers the majority of conventional pharmaceutical formulations (tablets, capsules, syrups, topicals, etc.)

The FSC is issued to the manufacturer (or their authorised representative/exporter), and it covers specific products at a specific manufacturing facility.

---

When Do Importing Countries Require It?

Most developing-market regulatory authorities require an FSC as part of product import registration, including many countries in:

- Africa: Regulatory authorities across East, West, and Southern Africa commonly require FSC/CPP as part of product dossier submissions - Southeast Asia: Countries such as Vietnam, Philippines, Myanmar, and others typically require FSC/CPP - Middle East: GCC countries (Saudi Arabia, UAE, Kuwait, etc.) generally require FSC/CPP for drug registration - Latin America: Many Latin American regulatory authorities require FSC/CPP

Some markets accept the FSC directly; others require it to be apostilled (under the Hague Convention on Apostille) or legalised through consular channels. Confirm the specific requirement with your local regulatory consultant.

---

How Long Does It Take?

FSC processing times vary: - CDSCO-issued CPP: Can take several weeks to months, depending on workload and completeness of application - State FDA-issued FSC: Timelines vary by state; some states process faster than others

---

WHO CPP vs. General FSC

Some regulatory authorities specifically require the WHO CPP format (as defined in WHO Technical Report Series, Annex 10 of WHO TRS 863 or subsequent updates). The CPP format includes specific fields such as:

- Product name, dosage form, strength - Composition (active and significant excipients) - Manufacturer details and licence information - Statement of whether the product is licensed and marketed in India - Statement of GMP status of the manufacturer

If your country requires the WHO CPP format specifically, confirm this with your regulatory consultant and advise your Indian supplier accordingly — the application to CDSCO or State FDA needs to specify the format required.

---

Bharat Medex's Role

We coordinate FSC/CPP applications as part of our export documentation service for buyers who require them. We advise buyers on realistic lead times and initiate applications in parallel with commercial order processing where possible.